超音波内视镜市场、机会、成长动力、产业趋势分析与预测，2024-2032

Endoscopic Ultrasound Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年07月10日 | 出版商:

Global Market Insights Inc. | 英文 135 Pages | 商品交期: 2-3个工作天内

价格

简介目录

在胃肠道 (GI) 疾病发生率上升和微创诊断程序进步的推动下，全球内视镜超音波 (EUS) 市场从 2024 年到 2032 年将实现 6.9% 的复合年增长率。据世界卫生组织称，消化系统疾病是全球发病和死亡的主要原因之一，由于人口老化和生活方式的改变，其盛行率预计将上升。 EUS 是一种结合内视镜检查和超音波的混合技术，已成为诊断和分期胃肠道癌症、胰臟疾病和其他疾病的重要工具。 EUS 以其精确性、缩短的恢復时间和较低的併发症风险而得到越来越多的采用，支持了全球市场的扩张。

内视镜超音波市场根据组件、应用、最终用途和区域进行细分。

在预测期内，针头部分将在内视镜超音波市场中取得显着成长。 EUS 引导下的细针抽吸 (FNA) 和细针活检 (FNB) 已成为从胰腺和淋巴结等难以接近的区域获取组织样本的标准程序。对微创诊断技术（特别是癌症分期和诊断）的需求不断增长，推动了 EUS 针的采用。针头设计的创新、灵活性和精确度的提高以及对早期癌症检测的日益重视都有助于细分市场的成长。

到 2032 年，由于胰臟癌、食道癌和慢性胰臟炎等胃肠道疾病的盛行率不断上升，胃肠病学领域将主导超音波内视镜市场。 EUS 正在成为胃肠病学家的首选方法，因为它能够提供消化道和周围器官的详细图像，促进准确的诊断和治疗计划。胃肠道疾病的增加，加上对侵入性较小的诊断选择的需求，正在推动 EUS 在胃肠病学中的广泛使用。

在发达的医疗基础设施、高额医疗支出以及对癌症筛检计画的高度重视的支持下，欧洲内视镜超音波市场将从 2024 年到 2032 年经历显着增长。该地区人口老化，加上胃肠道癌和胰腺癌的高发病率，正在推动对 EUS 等先进诊断工具的需求。此外，旨在早期癌症检测的政府倡议以及领先医疗设备製造商的存在正在促进整个欧洲 EUS 技术的创新和采用。

产业生态系统分析
产业影响力
- 成长动力
  - 胃肠道疾病发生率上升
  - 技术进步
  - 优惠报销政策
  - 微创手术的需求不断增加
- 产业陷阱与挑战
  - 严格的监管框架
  - EUS 设备和程序成本高昂
成长潜力分析
报销场景
监管环境
技术景观
未来市场趋势
管道分析
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司市占率分析
公司矩阵分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按组成部分，2021 - 2032 年

主要趋势
内视镜
- 线性内视镜
- 径向内视镜
针
- 细针抽吸 (FNA) 针
- 细针切片检查 (FNB) 针
超音波处理器
影像系统
超音波探头
其他组件

第 6 章：市场估计与预测：按应用分类，2021 - 2032

主要趋势
肿瘤学
胃肠病学
其他应用

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

主要趋势
医院
门诊手术中心
其他最终用户

第 8 章：市场估计与预测：按地区划分，2021 - 2032 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区

第 9 章：公司简介

B.Braun
Boston Scientific Corporation
ConMed
Cook Medical
FUJIFILM Holdings Corporation
HUACO HEALTHCARE TECHNOLOGIES CO. LTD
Medi-Globe Corporation
Medtronic plc
NIHON DEMPA KOGYO CO., LTD.
PENTAX Medical
Philips
SMITH and NEPHEW
SonoScape Medical Corp.
STERIS plc

简介目录

Product Code: 10191

Global Endoscopic Ultrasound (EUS) Market will achieve a 6.9% CAGR from 2024 to 2032, driven by the rising incidence of gastrointestinal (GI) disorders and advancements in minimally invasive diagnostic procedures. According to the World Health Organization, digestive diseases are among the leading causes of morbidity and mortality worldwide, with the prevalence expected to rise due to aging populations and lifestyle changes. EUS, a hybrid technique combining endoscopy and ultrasound, has become a crucial tool for diagnosing and staging GI cancers, pancreatic diseases, and other conditions. The growing adoption of EUS for its precision, reduced recovery times, and lower risk of complications supports the expansion of the market globally.

The Endoscopic Ultrasound Market is segmented based on Component, Application, End-use, and Region.

The needle segment will register notable gains in the Endoscopic Ultrasound Market over the forecast period. EUS-guided fine needle aspiration (FNA) and fine needle biopsy (FNB) have become standard procedures for obtaining tissue samples from difficult-to-access areas, such as the pancreas and lymph nodes. The increasing demand for minimally invasive diagnostic techniques, particularly for cancer staging and diagnosis, drives the adoption of EUS needles. Innovations in needle design, enhancing flexibility and precision, and the growing emphasis on early cancer detection contribute to segment growth.

The gastroenterology segment will dominate the Endoscopic Ultrasound Market through 2032, fueled by the increasing prevalence of gastrointestinal diseases, including pancreatic cancer, esophageal cancer, and chronic pancreatitis. EUS is becoming a preferred method for gastroenterologists due to its ability to provide detailed images of the digestive tract and surrounding organs, facilitating accurate diagnosis and treatment planning. The rise in GI disorders, coupled with the demand for less invasive diagnostic options, is driving the widespread use of EUS in gastroenterology.

Europe Endoscopic Ultrasound Market will experience significant growth from 2024 to 2032, supported by a well-developed healthcare infrastructure, high healthcare expenditure, and a strong focus on cancer screening programs. The region's aging population, combined with a high prevalence of gastrointestinal and pancreatic cancers, is driving demand for advanced diagnostic tools like EUS. Furthermore, government initiatives aimed at early cancer detection and the presence of leading medical device manufacturers are fostering innovation and adoption of EUS technology across Europe.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising incidence of gastrointestinal diseases
  - 3.2.1.2 Technological advancements
  - 3.2.1.3 Favorable reimbursement policies
  - 3.2.1.4 Increasing demand for minimally invasive procedures
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Stringent regulatory framework
  - 3.2.2.2 High cost of EUS equipment and procedures
3.3 Growth potential analysis
3.4 Reimbursement scenario
3.5 Regulatory landscape
3.6 Technological landscape
3.7 Future market trends
3.8 Pipeline analysis
3.9 Porter's analysis
3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Component, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Endoscope
- 5.2.1 Linear endoscopes
- 5.2.2 Radial endoscopes
5.3 Needle
- 5.3.1 Fine needle aspiration (FNA) needles
- 5.3.2 Fine needle biopsy (FNB) needles
5.4 Ultrasonic processors
5.5 Imaging systems
5.6 Ultrasound probe
5.7 Other components

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Oncology
6.3 Gastroenterology
6.4 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Hospitals
7.3 Ambulatory surgical centers
7.4 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa